CT
CERE

Cambridge Trust’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Cambridge Trust’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-250
Closed -$10.6K – 726
2023
Q4 		$10.6K Buy
+250
New +$10.6K ﹤0.01% 566